Table 3.
Strengths | Weaknesses |
---|---|
ATA guidelines;
|
hypothyroidism. |
Opportunities | Threats |
Given there is no strong recommendation force for the decision on the best screening method, this study highlights the need for an individualized evaluation and future randomized controlled trials to reach a high level of evidence data to guide clinical practice. |
Uncertainty of TSH reference range in pregnancy and if levothyroxine treatment can improve outcomes. |